Literature DB >> 1893617

IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus.

T H Winkler1, S Jahn, J R Kalden.   

Abstract

We describe the production of six mouse-human heterohybridomas secreting human IgG anti-dsDNA antibodies derived from patients with systemic lupus erythematosus (SLE). Peripheral blood cells used for fusion experiments were from patients who were shown to have high numbers of anti-DNA secreting B cells in the peripheral blood. All monoclonal antibodies bind to dsDNA in ELISA systems, five are reactive with Crithidia lucilae kinetoplasts and three precipitate dsDNA in the Farr assay. Inhibition studies revealed a remarkable specificity for certain polynucleotide structures. To our knowledge these are the first hybridomas described in the human system that secrete anti-dsDNA antibodies of the IgG class.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893617      PMCID: PMC1535604          DOI: 10.1111/j.1365-2249.1991.tb05735.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Immunology of DNA. V. Analysis of DNA/anti-DNA complexes.

Authors:  L A Aarden; E R De Groot; F Lakmaker
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

2.  The antibody repertoire of hybrid cell lines obtained by fusion of X63-AG8 myeloma cells with mitogen-activated B-cell blasts.

Authors:  J Andersson; F Melchers
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

3.  Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus.

Authors:  A J Swaak; L A Aarden; L W Statius van Eps; T E Feltkamp
Journal:  Arthritis Rheum       Date:  1979-03

4.  Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity?

Authors:  R J Smeenk; W A Lucassen; T J Swaak
Journal:  Arthritis Rheum       Date:  1987-06

Review 5.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

6.  Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay.

Authors:  B Friguet; A F Chaffotte; L Djavadi-Ohaniance; M E Goldberg
Journal:  J Immunol Methods       Date:  1985-03-18       Impact factor: 2.303

7.  Nucleotide sequence of the repressor gene of the RA1 tetracycline resistance determinant: structural and functional comparison with three related Tet repressor genes.

Authors:  B Unger; G Klock; W Hillen
Journal:  Nucleic Acids Res       Date:  1984-10-25       Impact factor: 16.971

8.  Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates.

Authors:  F Ebling; B H Hahn
Journal:  Arthritis Rheum       Date:  1980-04

9.  Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities.

Authors:  T Ternynck; S Avrameas
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988

10.  Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics.

Authors:  J Rauch; H Massicotte; H Tannenbaum
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

View more
  14 in total

Review 1.  Impaired clearance of apoptotic cells in systemic lupus erythematosus: challenge of T and B cell tolerance.

Authors:  Susanne Kuenkele; Thomas D Beyer; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

2.  The evolution of human anti-double-stranded DNA autoantibodies.

Authors:  Ute Wellmann; Miriam Letz; Martin Herrmann; Sieglinde Angermüller; Joachim R Kalden; Thomas H Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

3.  Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells.

Authors:  Manar Kalaaji; Elin Mortensen; Leif Jørgensen; Randi Olsen; Ole Petter Rekvig
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

4.  Targeted silencing of DNA-specific B cells combined with partial plasma cell depletion displays additive effects on delaying disease onset in lupus-prone mice.

Authors:  K A Nikolova-Ganeva; V V Gesheva; T A Todorov; R E Voll; T L Vassilev
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

5.  Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis.

Authors:  Abdul Hakkim; Barbara G Fürnrohr; Kerstin Amann; Britta Laube; Ulrike Abu Abed; Volker Brinkmann; Martin Herrmann; Reinhard E Voll; Arturo Zychlinsky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 6.  Host controls of HIV broadly neutralizing antibody development.

Authors:  Garnett Kelsoe; Barton F Haynes
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

7.  Repertoire cloning of lupus anti-DNA autoantibodies.

Authors:  P Roben; S M Barbas; L Sandoval; J M Lecerf; B D Stollar; A Solomon; G J Silverman
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

8.  Human autoantibody recognition of DNA.

Authors:  S M Barbas; H J Ditzel; E M Salonen; W P Yang; G J Silverman; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Expansion of a B-lymphocyte clone producing IgM auto-antibodies encoded by a somatically mutated VHI gene in the spleen of an autoimmune patient.

Authors:  S Jahn; B Niemann; T Winkler; J R Kalden; R von Baehr
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

10.  Production and analysis of IgG monoclonal anti-DNA antibodies from systemic lupus erythematosus (SLE) patients.

Authors:  M Ehrenstein; C Longhurst; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.